Free Trial
NASDAQ:OXBR

Oxbridge Re Q1 2026 Earnings Report

Oxbridge Re logo
$0.98 +0.00 (+0.50%)
As of 12:23 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Oxbridge Re EPS Results

Actual EPS
N/A
Consensus EPS
-$0.03
Beat/Miss
N/A
One Year Ago EPS
N/A

Oxbridge Re Revenue Results

Actual Revenue
N/A
Expected Revenue
$0.70 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Oxbridge Re Announcement Details

Quarter
Q1 2026
Time
After Market Closes
Conference Call Date
Monday, May 11, 2026
Conference Call Time
4:30PM ET

Conference Call Resources

Oxbridge Re Earnings Headlines

Oxbridge Re (OXBR) Projected to Post Quarterly Earnings on Monday
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel
See More Oxbridge Re Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Oxbridge Re? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Oxbridge Re and other key companies, straight to your email.

About Oxbridge Re

Oxbridge Re (NASDAQ:OXBR) (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents. Oxbridge Re works closely with insurers to structure agreements that align risk retention levels, collateral requirements, and profit-sharing mechanics. These arrangements often feature customized features such as experience refunds, corridor enhancements, and risk corridors, providing clients with flexibility in managing long-term liabilities.

Oxbridge Re serves a diversified client base across North America, focusing primarily on life, annuity, and disability insurance portfolios. Its underwriting team brings experience in actuarial modeling, financial analysis, and regulatory compliance, supporting transactions that span single-life, group life, living benefits, and specialized guarantee products. While relatively new to the public markets, Oxbridge Re has built strategic alliances with financial institutions and reinsurers to broaden its capital resources and co‐reinsurance capabilities.

Governed by a board with backgrounds in insurance operations, capital markets, and risk management, Oxbridge Re emphasizes disciplined underwriting standards and capital-efficient structuring. The company aims to differentiate itself through innovative deal design and responsive client service, positioning its platform to address evolving regulatory requirements and competitive pressures within the reinsurance industry.

View Oxbridge Re Profile